These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 16006965)
21. Expression of hepatocyte growth factor and its receptor C-met in acquired renal cystic disease associated with renal cell carcinoma. Konda R; Sato H; Hatafuku F; Nozawa T; Ioritani N; Fujioka T J Urol; 2004 Jun; 171(6 Pt 1):2166-70. PubMed ID: 15126778 [TBL] [Abstract][Full Text] [Related]
22. Stage-specific roles of fibulin-5 during oxidative stress-induced renal carcinogenesis in rats. Ohara H; Akatsuka S; Nagai H; Liu YT; Jiang L; Okazaki Y; Yamashita Y; Nakamura T; Toyokuni S Free Radic Res; 2011 Feb; 45(2):211-20. PubMed ID: 20942562 [TBL] [Abstract][Full Text] [Related]
23. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis. Mizutani Y; Nakanishi H; Li YN; Matsubara H; Yamamoto K; Sato N; Shiraishi T; Nakamura T; Mikami K; Okihara K; Takaha N; Ukimura O; Kawauchi A; Nonomura N; Bonavida B; Miki T Int J Oncol; 2007 Apr; 30(4):919-25. PubMed ID: 17332931 [TBL] [Abstract][Full Text] [Related]
25. Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Schwarz A; Vatandaslar S; Merkel S; Haller H Clin J Am Soc Nephrol; 2007 Jul; 2(4):750-6. PubMed ID: 17699492 [TBL] [Abstract][Full Text] [Related]
34. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma. Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908 [TBL] [Abstract][Full Text] [Related]
35. Radiosensitization by inhibiting STAT1 in renal cell carcinoma. Hui Z; Tretiakova M; Zhang Z; Li Y; Wang X; Zhu JX; Gao Y; Mai W; Furge K; Qian CN; Amato R; Butler EB; Teh BT; Teh BS Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):288-95. PubMed ID: 19100922 [TBL] [Abstract][Full Text] [Related]
36. The pT1a and pT1b category subdivision in renal cell carcinoma: is it reflected by differences in tumour biology? Langner C; Ratschek M; Rehak P; Tsybrovskyy O; Zigeuner R BJU Int; 2005 Feb; 95(3):310-4. PubMed ID: 15679784 [TBL] [Abstract][Full Text] [Related]
37. Chromophobe renal cell carcinoma and 'capsulomas' with acquired cystic disease of the kidney in a long-term hemodialysis patient. Nishihara K; Shomori K; Nagashima Y; Kuroda N; Nagamatsu H; Ito H Int J Urol; 2008 Jun; 15(6):543-5. PubMed ID: 18489645 [TBL] [Abstract][Full Text] [Related]
38. Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues. Perego RA; Bianchi C; Corizzato M; Eroini B; Torsello B; Valsecchi C; Di Fonzo A; Cordani N; Favini P; Ferrero S; Pitto M; Sarto C; Magni F; Rocco F; Mocarelli P J Proteome Res; 2005; 4(5):1503-10. PubMed ID: 16212400 [TBL] [Abstract][Full Text] [Related]
39. Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma. Betsunoh H; Mukai S; Akiyama Y; Fukushima T; Minamiguchi N; Hasui Y; Osada Y; Kataoka H Cancer Sci; 2007 Apr; 98(4):491-8. PubMed ID: 17309599 [TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of Id-1 and its association with EGFR in renal cell cancer. Li X; Zhang Z; Xin D; Chua CW; Wong YC; Leung SC; Na Y; Wang X Histopathology; 2007 Mar; 50(4):484-90. PubMed ID: 17448024 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]